Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019)
Lineage Cell Therapeutics' (LCTX) quarterly Notes Payables came in at $18000.0 in Q1 2019, down 85.0% year-on-year from $120000.0 in Q1 2018, and down 74.29% quarter-over-quarter from $70000.0 in Q4 2018.
Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019) Analysis & Trends
Lineage Cell Therapeutics' Notes Payables history runs 5 years deep, the most recent figure standing at $18000.0 for Q1 2019.
- On a quarterly basis, Notes Payables fell 85.0% year-over-year to $18000.0 in Q1 2019; TTM through Mar 2019 was $18000.0, a 85.0% decrease from a year earlier, with the FY2018 full-year figure at $70000.0, down 53.95% from the prior year.
- Notes Payables declined to $18000.0 in Q1 2019 per LCTX's latest filing, from $70000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $2.6 million in Q2 2017 and bottomed at $18000.0 in Q1 2019.
- The 5-year median for Notes Payables is $97000.0 (2015), against an average of $260437.5.
- Across the five-year window, Notes Payables soared 2589.47% in 2017 and sank 95.3% in 2018, its largest moves.
- Year by year, Notes Payables stood at $95000.0 in 2015, then advanced by 4.21% to $99000.0 in 2016, then jumped by 53.54% to $152000.0 in 2017, then sank by 53.95% to $70000.0 in 2018, then plunged by 74.29% to $18000.0 in 2019.
- Per Business Quant, the three latest LCTX Notes Payables figures stand at $18000.0 (Q1 2019), $70000.0 (Q4 2018), and $70000.0 (Q3 2018).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | 70,000.00 |
| Sep 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 120,000.00 |
| Mar 31, 2018 | 120,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Sep 30, 2017 | 126,000.00 |
| Jun 30, 2017 | 2.56 Mn |
| Mar 31, 2017 | 124,000.00 |
| Dec 31, 2016 | 99,000.00 |
| Sep 30, 2016 | 95,000.00 |
| Jun 30, 2016 | 95,000.00 |
| Mar 31, 2016 | 95,000.00 |
| Dec 31, 2015 | 95,000.00 |
| Sep 30, 2015 | 95,000.00 |
| Jun 30, 2015 | 238,000.00 |